A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Patients With Moderate to Severe Atopic Dermatitis
收藏DataCite Commons2025-10-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011869/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of baricitinib as monotherapy in participants with moderate to severe atopic dermatitis.
提供机构：
Vivli
创建时间：
2025-10-17
